explore -WSS

explore

author：comprehensive 2025-10-02 00:18:18 - browse：59371

Terry Horgan pictured at home -- coverage from STAT — Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： FDA panel to weigh approval of NurOwn, controversial ALS drug

focus

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Why are Kaiser Permanente staff considering a strike?

A strong 6.5

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

EpiPen alternative approval delay highlights citizen petition issue

Second xenotransplant done with gene

knowledge

explore

focus

Novavax promises a turnaround & Lilly roils the obesity market

Johnson & Johnson sues to stop Medicare negotiation

Cancer drug shortages should be causing more outrage

BridgeBio heart drug succeeds in pivotal study

How one medical school became remarkably diverse

BridgeBio heart drug succeeds in pivotal study

Novavax promises a turnaround & Lilly roils the obesity market

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

In age of alternative facts, a scholarly course on calling out crap

How AI helped researchers track recovery from depression

knowledge

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

More hospitals are billing patients as online messages surge

Flagship, Pfizer team up in deal worth up to $7 billion

Emergency workers more likely to restrain Black patients: study

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

leisure time

entertainment

focus

explore